Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...

She says they have done what the diet industry could never do for her - free her from a life controlled by food. From a very ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

This is a mistake. GLP-1s appear to modify addictive brain pathways that are activated by ultraformulated foods, helping ...

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

The State’s medicines bill would more than double to €10 billion per year if it funded weight loss drugs for all who would likely benefit from them, the head of the national pharmacoeconomics ...

Dr Naheed Ali, a physician and Senior Contributor at Vera Clinic, explains: “Ozempic face is not exclusive to these drugs, any significant weight loss can lead to changes in facial structure.

Ozempic feet (1 Trusted Source GLP-1 diabetes and weight-loss drug side effects: "Ozempic face" and more Go to source). While the face often draws attention when weight loss is dramatic ...

Zepbound's prospects still look bright, but some recent developments point to another weight loss drug that could become yet another powerful growth driver for Lilly. Let's look deeper into the ...

said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss drugs Mounjaro and Zepbound. The lawsuits, against Mochi ...

Pfizer is ending the development of its GLP-1 weight loss drug, danuglipron. A patient in a clinical trial experienced a liver injury, potentially due to the drug. Pfizer has a massive pipeline ...